Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice

British Journal of Pharmacology

Volumn 135, Issue 5, 2002, Pages 1213-1218

  Klein, André ^a   Pinho, Vanessa ^a   Alessandrini, Ana Letícia ^a   Shimizu, Takao ^b   Ishii, Satoshi ^b   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemokines; Eosinophils; Eotaxin; Platelet activating factor; Recruitment

Indexed keywords

EOTAXIN; G PROTEIN COUPLED RECEPTOR; MODIPAFANT; RECOMBINANT CYTOKINE; RECOMBINANT EOTAXIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EOSINOPHIL; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PLEURA CAVITY; PLEURISY; PRIORITY JOURNAL; SENSITIZATION; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PLEURA; PLEURISY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 0036198296     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704570     Document Type: Article

References (34)

1. UK-74505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo
2. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro
3. Blockade of PAF receptors controls IL-8 production by regulating the activation of neutrophil CD11/CD18
4. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG
5. Scorpion venom-induced neutrophilia is inhibited by a PAF receptor antagonist in the rat
6. Mechanisms underlying eosinophil trafficking and their relevance in vivo
7. A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment
8. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses
9. Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo
10. Pharmacology of the eosinophil
11. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors
12. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
13. Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man
14. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo
15. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating receptor
16. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
17. Modipant, a new PAF antagonist: Pharmacokinetics and disposition in rat, dog and man
18. 4
19. Stem cell factor-induced leukotriene B(4) production cooperates with eotaxin to mediate the recruitment of eosinophils during allergic pleurisy in mice
20. Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma
21. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: Eosinophil chemoattractant and priming agent and epithelial cell activator
22. Chemokines and asthma: Redundancy of function or a coordinated effort?
23. PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk
24. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury
25. International union of pharmacology. XXII. Nomenclature for chemokine receptors
26. Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation
27. Mechanisms involved in eosinophil migration. Platelet-activating factor-induced chemotaxis and interleukin-5-induced chemokines are mediated by different signals
28. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats
29. 4- and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo
30. Role of CD11/CD18 in mediating cutaneous inflammation in the guinea pig
31. Chemokine-induced eosinophil recruitment: Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin
32. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo
33. Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles
34. Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils